EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische Studie

Predicting Malignant Ventricular Arrhythmias Using Real-Time Remote Monitoring

Curtis Ginder, Jin Li, Jonathan L Halperin, Joseph G Akar, David T Martin, Ishanu Chattopadhyay, Gaurav A Upadhyay

Journal of the American College of Cardiology · 2023-03 · 81 (10) · 949-961

DOI: 10.1016/j.jacc.2022.12.024 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of the American College of Cardiology, 2023-03. Verfasst von Curtis Ginder und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiovascular Medicine, Department of Internal Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, US…. Hauptthemen laut MEDLINE: Atrial Fibrillation, Tachycardia, Ventricular, Defibrillators, Implantable. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 47 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Although implantable cardioverter-defibrillator (ICD) therapies are associated with increased morbidity and mortality, the prediction of malignant ventricular arrhythmias has remained elusive. OBJECTIVES: The purpose of this study was to evaluate whether daily remote-monitoring data may predict appropriate ICD therapies for ventricular tachycardia or ventricular fibrillation. METHODS: This was a post hoc analysis of IMPACT (Randomized trial of atrial arrhythmia monitoring to guide anticoagulation in patients with implanted defibrillator and cardiac resynchronization devices), a multicenter, randomized, controlled trial of 2,718 patients evaluating atrial tachyarrhythmias and anticoagulation for patients with heart failure and ICD or cardiac resynchronization therapy with defibrillator devices. All device therapies were adjudicated as either appropriate (to treat ventricular tachycardia or ventricular fibrillation) or inappropriate (all others). Remote monitoring data in the 30 days before device therapy were utilized to develop separate multivariable logistic regression and neural network models to predict appropriate device therapies. RESULTS: A total of 59,807 device transmissions were available for 2,413 patients (age 64 ± 11 years, 26% women, 64% ICD). Appropriate device therapies (141 shocks, 10 antitachycardia pacing) were delivered to 151 patients. Logistic regression identified shock lead impedance and ventricular ectopy as significantly associated with increased risk of appropriate device therapy (sensitivity 39%, specificity 91%, AUC: 0.72). Neural network modeling yielded significantly better (P < 0.01 for comparison) predictive performance (sensitivity 54%, specificity 96%, AUC: 0.90), and also identified patterns of change in atrial lead impedance, mean heart rate, and patient activity as predictors of appropriate therapies. CONCLUSIONS: Daily remote monitoring data may be utilized to predict malignant ventricular arrhythmias in the 30 days before device therapies. Neural networks complement and enhance conventional approaches to risk stratification.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationTachycardia, VentricularDefibrillators, ImplantableHumansFemaleMiddle AgedAgedMaleVentricular FibrillationAnticoagulantsTreatment Outcome

Stichwörter der Autor:innen

artificial intelligenceimplantable defibrillator shocksmachine learningventricular fibrillationventricular tachycardia

Substanzen

Anticoagulants

Autor:innen und Institutionen

  • Division of Cardiovascular Medicine, Department of Internal Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Department of Computer Science, The University of Chicago, Chicago, Illinois, USA.
  • Cardiovascular Institute, Mount Sinai Medical Center, New York, New York, USA.
  • Cardiac Electrophysiology, Yale University School of Medicine, New Haven, Connecticut, USA.
  • Department of Hospital Medicine, The University of Chicago Pritzker School of Medicine, Chicago, Illinois, USA.
  • Center for Arrhythmia Care, Heart and Vascular Institute, The University of Chicago Pritzker School of Medicine, Chicago, Illinois, USA. Electronic address: https://twitter.com/gauravaupadhyay.

Zitieren

APA

Ginder, C., Li, J., Halperin, J. L., Akar, J. G., Martin, D. T., Chattopadhyay, I., & Upadhyay, G. A. (2023). Predicting Malignant Ventricular Arrhythmias Using Real-Time Remote Monitoring. Journal of the American College of Cardiology, 81(10), 949-961. https://doi.org/10.1016/j.jacc.2022.12.024

Vancouver

Ginder C, Li J, Halperin JL, Akar JG, Martin DT, Chattopadhyay I, et al. Predicting Malignant Ventricular Arrhythmias Using Real-Time Remote Monitoring. Journal of the American College of Cardiology. 2023;81(10):949-961. doi:10.1016/j.jacc.2022.12.024

BibTeX
@article{Ginder2023,
  author = {Ginder, Curtis and Li, Jin and Halperin, Jonathan L and Akar, Joseph G and Martin, David T and Chattopadhyay, Ishanu and Upadhyay, Gaurav A},
  title = {Predicting Malignant Ventricular Arrhythmias Using Real-Time Remote Monitoring},
  journal = {Journal of the American College of Cardiology},
  year = {2023},
  volume = {81},
  number = {10},
  pages = {949--961},
  doi = {10.1016/j.jacc.2022.12.024}
}
Kostenlos starten →